This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n11http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45976168
rdf:type
wikibase:Item
schema:description
2009年学术文章 bilimsel makale vetenskaplig artikel 2009年學術文章 գիտական հոդված научная статья wissenschaftlicher Artikel 2009年學術文章 tudományos cikk artículu científicu vedecký článok სამეცნიერო სტატია บทความทางวิทยาศาสตร์ article scientifique (publié 2009) מאמר מדעי wetenschappelijk artikel наукова стаття, опублікована в червні 2009 tieteellinen artikkeli artykuł naukowy مقالة علمية 2009年學術文章 научни чланак 2009年學術文章 artikull shkencor 2009년 논문 мақолаи илмӣ articolo scientifico 2009年学术文章 vitenskapelig artikkel научна статия mokslinis straipsnis artigo científico (publicado na 2009) 2009年學術文章 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ scienca artikolo bài báo khoa học artigo científico article scientific επιστημονικό άρθρο 2009 nî lūn-bûn vitskapeleg artikkel videnskabelig artikel (udgivet 2009) 2009年学术文章 vědecký článek 2009年學術文章 مقالهٔ علمی article científic teaduslik artikkel 2009年学术文章 2009年の論文 artigo científico (publicado na 2009) artículo científico publicado en 2009 naučni članak 2009年学术文章 articol științific سائنسی مضمون научни чланак artikulong pang-agham scientific article
p:P577
wds:Q45976168-74B87F00-76E4-49BF-83D6-FC57BAE97C79
wdt:P577
2009-06-09T00:00:00Z
p:P407
wds:Q45976168-EF4D325A-89A3-418C-A15D-E42B3CF85BC9
wdt:P407
wd:Q1860
p:P2093
wds:Q45976168-568ED729-C891-4EC0-A079-83EDC0729718 wds:Q45976168-2EA1ECA5-91FD-4AB6-A3ED-03D5C87B1B8E wds:Q45976168-31D2D193-5228-46B3-9687-32FDC6CFB267 wds:Q45976168-A8172B5C-ADBC-4149-BACE-50BBBFB11A18 wds:Q45976168-A76E946B-C701-4C6A-8F84-DC098A861FFC wds:Q45976168-8B5065E5-2B3F-431E-9AD9-9084060C4E6E wds:Q45976168-7E02B25B-C0B7-48FB-8F6B-6812F9045A0F wds:Q45976168-121B8AE9-966B-43C1-84BE-22CA47068C98 wds:Q45976168-14128DAB-B0E9-4DE5-B848-1897D0DCBE98
wdt:P2093
Shawna Savage Shermini Saini A Benjamin Suttle Diana M Gibson Afshin Dowlati Elmar M Merkle Lini Pandite Jeffrey P Hodge Herbert I Hurwitz
rdfs:label
Phase I trial of pazopanib in patients with advanced cancer. Phase I trial of pazopanib in patients with advanced cancer.
skos:prefLabel
Phase I trial of pazopanib in patients with advanced cancer. Phase I trial of pazopanib in patients with advanced cancer.
schema:name
Phase I trial of pazopanib in patients with advanced cancer. Phase I trial of pazopanib in patients with advanced cancer.
p:P1476
wds:Q45976168-A4E3CC5C-E535-4635-BD48-55EB78530480
wdt:P1476
Phase I trial of pazopanib in patients with advanced cancer.
p:P304
wds:Q45976168-BC79C253-7809-427B-95C2-1D34581C8D92
wdt:P304
4220-4227
p:P31
wds:Q45976168-421028F6-D56A-4A71-8895-B023A77A8B81
wdt:P31
wd:Q13442814
p:P921
wds:Q45976168-E431251E-7E49-4921-888E-2F805C77123E wds:Q45976168-E59C9824-FF91-4D23-AE9A-499D94F73E20
wdt:P921
wd:Q181600 wd:Q5452194
p:P698
wds:Q45976168-F4F6CF4C-F2F1-443D-A6AD-15EB643FD90C
wdtn:P698
n12:19509175
wdt:P698
19509175
p:P1433
wds:Q45976168-E375DA98-6B8B-4053-BA8F-571FC03B4483
wdt:P1433
wd:Q332253
p:P433
wds:Q45976168-3E997A2E-11E0-4950-AD4F-2921C4F98165
p:P478
wds:Q45976168-5E8776FD-9475-458F-B515-8E4E65D7E326
wdt:P433
12
wdt:P478
15
p:P356
wds:Q45976168-9B0E25D2-034A-4D9E-AE8E-D5CB2D3A634E
wdtn:P356
n11:1078-0432.CCR-08-2740
wdt:P356
10.1158/1078-0432.CCR-08-2740